The Study of Genes Localization for Female Pelvic Floor Dysfunction
PFD POP UI
The Study of Susceptibility Genes Localization for Female Pelvic Floor Dysfunction
1 other identifier
observational
200
1 country
1
Brief Summary
Female pelvic floor dysfunction (FPD) is due to defects in the pelvic support structures, degradation, damage or dysfunction. The main problem of which is pelvic organ prolapse(POP), urinary incontinence(UI) and genital tract injury. Although it does not pose a serious threat to life, but affect the patient's quality of life seriously in the physical, psychological, social behavior and other aspects. With the growing aging population, the incidence rate has gradually increased, and increasing demands for people's quality of life simultaneously, more and more attention was raised to PFD as common chronic diseases. In recent years, the basic research, epidemiology, prevention, diagnosis and treatment of PFD have made great progress, especially in developing gynecological urology theory and reconstructive pelvic surgery. But overall the basic research of PFD is lagging behind, especially susceptibility gene localization and functional studies did not get enough attention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 10, 2014
CompletedFirst Posted
Study publicly available on registry
June 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedJune 18, 2014
June 1, 2014
2.9 years
February 10, 2014
June 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
susceptibility genes localization
Based on high-throughput sequencing platform, we expect to screen out susceptibility genes location in PFD, providing theoretical basis for individualized prevention, intervention and treatment.
4 years
Study Arms (2)
experiment group
patients with FPFD
control group
patients without FPFD
Eligibility Criteria
The experiment group are patients with PFD. While the control group are volunteer patients without PFD on the basis of informed consent.
You may qualify if:
- female aging from 30 to 70-year old;
- preoperative diagnosis of gynecologic malignancies;
- have the ability to comply with Research programs;
- voluntarily participate in the study and signed an informed consent form
You may not qualify if:
- patients with severe cardiovascular diseases, kidney, liver and other vital organs diseases, bone marrow disease and mental illness;
- patients suffering from autoimmune diseases;
- patients with acute infectious disease or infection early phase of infection;
- patients with urinary tract infection;
- patients with infection or erosion of ano-genital skin;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhiqing, Lianglead
- Shenzhen Huada Genomics Co., Ltd.collaborator
Study Sites (1)
Department of Obstetrics and Gynaecology, Southwest Hospital, Third Military
Chongqing, Chongqing Municipality, 400038, China
Biospecimen
The sample of blood, urine, cervical exfoliated cells and tissue of patients with POP, UI or genital tract injury should be used only in this research with informed consent. The remaining part will be Safekeeping. All information is strictly confidential.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Obstetrics and Gynecology
Study Record Dates
First Submitted
February 10, 2014
First Posted
June 18, 2014
Study Start
November 1, 2013
Primary Completion
October 1, 2016
Study Completion
October 1, 2017
Last Updated
June 18, 2014
Record last verified: 2014-06